Jones Christopher, Lemercinier Xavier
Laboratory for Molecular Structure, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Herts EN6 3QG, UK.
Carbohydr Res. 2005 Feb 28;340(3):403-9. doi: 10.1016/j.carres.2004.12.009.
The capsular polysaccharide from Streptococcus pneumoniae Type 15B is a component of the 23-valent polysaccharide vaccine against pneumococcal disease. We report full NMR assignments for the native and de-O-acetylated polysaccharide, and confirm that the phosphorylated substituent is glycerol-2-phosphate rather than phosphocholine, located on O-3 of the side chain beta-Galp residue. The polysaccharide is O-acetylated on the terminal alpha-Gal residue, distributed between O-2, O-3, O-4 and O-6 in a ratio of 6:12:12:55, with approximately 15% of the repeat units not O-acetylated.
来自15B型肺炎链球菌的荚膜多糖是23价肺炎球菌疾病多糖疫苗的一个成分。我们报告了天然和去O-乙酰化多糖的完整核磁共振归属,并确认磷酸化取代基是甘油-2-磷酸而不是磷酸胆碱,位于侧链β-Galp残基的O-3位。该多糖在末端α-Gal残基上发生O-乙酰化,在O-2、O-3、O-4和O-6之间的分布比例为6:12:12:55,约15%的重复单元未发生O-乙酰化。